UPDATE: Raymond James Downgrades Amgen (AMGN) to Market Perform, Following Trial Results Announcement
Tweet Send to a Friend
(Updated - October 8, 2020 1:01 PM EDT)
(updated to add analyst comments)Raymond James analyst Dane Leone downgraded Amgen ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updated to add analyst comments)Raymond James analyst Dane Leone downgraded Amgen ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE